Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02528331 · ClinicalTrials.gov registry record · NA

Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study

A NA study, sponsored by Duke University.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT02528331: Clinical Trial NA study, sponsored by Duke University.

NCT02528331 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02528331, a NA study, was terminated before completion, sponsored by Duke University.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effectiveness of repetitive TMS (rTMS) delivered simultaneously with elements of cognitive behavioral therapy/exposure-response prevention (CBT/ERP) in adult subjects (greater or equal to 18 years old) with obsessive-compulsive disorder (OCD). This is an open label study that involves standard of care for OCD (CBT) and an investigational treatment modality (TMS). The investigators will compare the Yale-Brown Obsessive Compulsive Scale (YBOCS) scores before and after treatment to quantify clinical improvement. The side effects from TMS include, but are not limited to, headache, seizure, and general pain. CBT has minimal side effects other than mental discomfort during the exposure sessions. For safety concerns, pregnant women and subjects with seizure-related history will be excluded as well as other indicated conditions in the details protocol.

Primary Outcome

Remission is defined as end-point Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score less than the value of 16.

Interventions

  • DEVICE Transcranial magnetic stimulation
  • BEHAVIORAL Cognitive behavioral therapy

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2016-03
Est. Completion 2016-08
Phase NA
Duke University

1,725 total trials

Why NCT02528331 stopped before completion

NCT02528331 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Transcranial magnetic stimulation is the first listed.

NCT02528331 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02528331 about?

NCT02528331 is a clinical study titled "Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study". The purpose of this study is to evaluate the effectiveness of repetitive TMS (rTMS) delivered simultaneously with elements of cognitive behavioral therapy/exposure-response prevention (CBT/ERP) in adult subjects (greater or equal to 18 years old) with obsessive-compulsive disorder (OCD). This is an ...

What is the current status of trial NCT02528331?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-03. Estimated completion is 2016-08.

What interventions are being tested in trial NCT02528331?

The interventions under investigation include: Transcranial magnetic stimulation (DEVICE), Cognitive behavioral therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02528331?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02528331's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02528331, the US trial registry maintained by the National Library of Medicine. NCT02528331 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.